2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.
Zoma Foster, PhD
Advertisement
Strategic Feasibility Manager, UCB
Articles by Zoma Foster, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
2
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
3
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
4
ACT Brief Weekly Recap: AI Innovation, Industry Resilience, and Supply Chain Readiness
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
